Rating History for Inhibikase Therapeutics Inc (IKT) by Ladenburg Thalmann

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/4/2026 Aydin Huseynov New Coverage Buy
(N/A)
4.00
(N/A)
1.91
(1.88)
-1.57% Details